NCT03673748 Treatment of Lupus Nephritis With Allogeneic Mesenchymal Stem Cells Status RECRUITING Phase PHASE2
NCT03664908 Detection of Anti-glomerular Basement Membrane Antibodies (Anti-GBM): a Promising Biomarker for Lupus Nephritis (LN)? Status COMPLETED Phase NA
NCT03610516 Safety, Pharmacokinetics and Preliminary Efficacy Study of CFZ533 in Patients With Lupus Nephritis. Status COMPLETED Phase PHASE2
NCT03597464 Aurinia Renal Assessments 2: Aurinia Renal Response in Lupus With Voclosporin Status COMPLETED Phase PHASE3
NCT03580291 Human Umbilical Cord Mesenchymal Stem Cells Treatment for Lupus Nephritis (LN) Status UNKNOWN Phase PHASE2
NCT03526042 Angiotensin-II Receptor Antibodies Blockade With Losartan in Patients With Lupus Nephritis Status UNKNOWN Phase NA
NCT03458156 Umbilical Cord Mesenchymal Stem Cell Transplantation for Lupus Nephritis Status UNKNOWN Phase NA
NCT03453619 Phase II Study Assessing Safety and Efficacy of APL-2 in Glomerulopathies Status COMPLETED Phase PHASE2
NCT03393013 A Study of KZR-616 in Patients With SLE With and Without Lupus Nephritis Status COMPLETED Phase PHASE1/PHASE2
NCT03385564 An Exploratory Maintenance Trial of BI 655064 in Patients With Lupus Nephritis Status COMPLETED Phase PHASE2
NCT03214731 Efficacy and Safety of Artesunate Plus Standard of Care in Active Lupus Nephritis Status UNKNOWN Phase PHASE4
NCT03201406 Retrospective Analysis of Renal Prognosis in Patients With Chronic Kidney Disease Status UNKNOWN Phase N/A
NCT03174587 Evaluate the Safety of CS20AT04 Inj. in Subjects With Lupus Nephritis Status COMPLETED Phase PHASE1
NCT02954939 The Effect of Mycophenolate Mofetil and Cyclophosphamide on the Lymphocyte Subsets in Patients With Proliferative Lupus Nephritis Status RECRUITING Phase NA